£150 discount off current BioTrinity delegate rate to offer to any BIVDA members who register using code:BIVDAMEM. Instruction: Delegates wishing to access the BIVDA discount must select that they are “associated organisation/promotional offer” and then enter the code in the association and promotional codes field. This code will be valid for use until 23rd March 2012. www.biotrinity.com
BIVDA members receive 10% off the registration fee
This meeting has been designed to provide cutting-edge, exclusive insights on how to successfully develop companion diagnostics with insights from the most influential drug and diagnostic developers.
quote ‘BIVDA’ when registering to claim your discount
26 – 29 March 2012 | Frankfurt
www.companion-dxeurope.com
Diagnostics Asia 24-26th August 2010
5th Annual Event, with a highly distinguished panel of speakers, including BIVDA's Doris-Ann Williams. Plus Pre-Conference Workshop on 24 August 2010 Tuesday Intellectual Property and Commercialization Strategies for Companion Diagnostics Development & Personalized Medicine
Following approval of this programme by the NICE Board, NICE will go out to public consultation on the process and methods guides of the Evaluation Pathway Programme for Medical Technologieson 18 June. We are organising a workshop for industry stakeholders on Tuesday 6 July from 10.30 am to 2.00 pm at the NICE offices in central Manchester.
16-17 June 2010 *Register Now*First Come First Serve Basis* Role and Significance of In Vitro-Diagnostics in the Healthcare Systems of the Future The increased use of In Vitro diagnostics (IvD) in healthcare is largely driven by their increasing use in chronic disease management (eg diabetes), pressure on healthcare providers to improve turnaround times, the use of point-of-care tests to reduce costs and their increasing use in non-hospital settings.
1st and 2nd July 2010 Medical School, University of Birmingham, United Kingdom *** Registration Open *** Call for Abstracts *** This international symposium attracts researchers actively involved in the development, evaluation or regulation of biomarkers, diagnostic modalities or other medical tests.
Mark Samuels (Roche Diagnostics) presented on IVDs and the new evaluation pathway at the NICE Conference on 2 December 2009.
The slides from his presentation can be downloaded here
The Irish Medicines Board (IMB) is the Competent Authority for In vitro Diagnostic Medical devices in Ireland. We will be holding an IVD Information Day on Friday 6th November 2009.
In November 2008, the Royal College of Pathologists organised its first ever National Pathology Week (NPW).
A to Z guide for POCT Co-ordinators ensuring quality and meeting standards - Wednesday 21st October 2009, City Inn, Leeds - see SKB Website
BIVDA lists events for information only and takes no responsibilty for any event except for those specifically organised by BIVDA BIVDA are not responsible for the content of external internet/web sites